Nematode movement along a chemical gradient in a structurally heterogeneous environment : 1 . Experiment

L'interaction entre l'hétérogénéité structurale et les gradients chimiques, ainsi que leur influence sur le déplacement des nématodes, ont été étudiées. Trois dispositifs expérimentaux ont été utilisés qui comprennent un nématode (#Caenorhabditis elegans) placé sur une couche homogène de milieu nutritif gélosé dans une boîte de Petri avec ou sans présence d'une source bactérienne de nourriture (#Escherichia coli) utilisée comme attractif. L'hétérogénéité structurale est réalisée en ajoutant des grains de sable en une seule épaisseur dans chacun des traitements homologues. Toutes les traces ont été relevées à l'aide d'un dispositif de vidéo à séquences temporelles et les données digitalisées avant analyse. Les répartitions des angles de changement de direction et les dimensions fractales des traces sont calculées pour chaque traitement. Il se révèle un effet statistiquement significatif (P inférieur ou égal à 0,01) de tous les traitements sur le déplacement des nématodes. En présence d'un produit attractif, le déplacement du nématode est plus linéaire et dirigé vers la source bactérienne. L'hétérogénéité structurale provoque un déplacement plus linéaire que dans le cas d'un milieu homogène. La dimension fractale des traces du nématode est significativement (P inférieur ou égal à 0,01) plus élevée pour les traitements sans sable ni bactéries que pour les autres traitements. Ces résultats permettent, pour la première fois, de quantifier le degré auquel les nématodes utilisent un comportement de recherche de nourriture au hasard dans un milieu homogène et adoptent un déplacement mieux orienté en présence d'un produit attractif. Finalement, lorsqu'une hétérogénéité est présente, la stratégie de recherche de nourriture devient plutôt une stratégie d'évitement permettant au nématode d'échapper aux "pièges" structuraux, tels les pores en cul-de-sac, et de pouvoir ainsi continuer à réagir à l'attraction. (Résumé d'auteur

Quantum Locality

It is argued that while quantum mechanics contains nonlocal or entangled states, the instantaneous or nonlocal influences sometimes thought to be present due to violations of Bell inequalities in fact arise from mistaken attempts to apply classical concepts and introduce probabilities in a manner inconsistent with the Hilbert space structure of standard quantum mechanics. Instead, Einstein locality is a valid quantum principle: objective properties of individual quantum systems do not change when something is done to another noninteracting system. There is no reason to suspect any conflict between quantum theory and special relativity.Comment: Introduction has been revised, references added, minor corrections elsewhere. To appear in Foundations of Physic

Consistent histories, the quantum Zeno effect, and time of arrival

We present a decomposition of the general quantum mechanical evolution operator, that corresponds to the path decomposition expansion, and interpret its constituents in terms of the quantum Zeno effect (QZE). This decomposition is applied to a finite dimensional example and to the case of a free particle in the real line, where the possibility of boundary conditions more general than those hitherto considered in the literature is shown. We reinterpret the assignment of consistent probabilities to different regions of spacetime in terms of the QZE. The comparison of the approach of consistent histories to the problem of time of arrival with the solution provided by the probability distribution of Kijowski shows the strength of the latter point of view

Output spectrum of a detector measuring quantum oscillations

We consider a two-level quantum system (qubit) which is continuously measured by a detector and calculate the spectral density of the detector output. In the weakly coupled case the spectrum exhibits a moderate peak at the frequency of quantum oscillations and a Lorentzian-shape increase of the detector noise at low frequency. With increasing coupling the spectrum transforms into a single Lorentzian corresponding to random jumps between two states. We prove that the Bayesian formalism for the selective evolution of the density matrix gives the same spectrum as the conventional master equation approach, despite the significant difference in interpretation. The effects of the detector nonideality and the finite-temperature environment are also discussed.Comment: 8 pages, 6 figure

Variation in The Vitamin D Receptor Gene is Associated With Multiple Sclerosis in an Australian Population

Multiple Sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system (CNS) resulting in accumulating neurological disability. The disorder is more prevalent at higher latitudes. To investigate VDR gene variation using three intragenic restriction fragment length polymorphisms (Apa I, Taq I and Fok I) in an Australian MS case-control population, one hundred and four Australian MS patients were studied with patients classified clinically as Relapsing Remitting MS (RR-MS), Secondary Progressive MS (SP-MS) or Primary Progressive MS (PP-MS). Also, 104 age-, sex-, and ethnicity-matched controls were investigated as a comparative group. Our results show a significant difference of genotype distribution frequency between the case and control groups for the functional exon 9 VDR marker Taq I (p_Gen = 0.016) and interestingly, a stronger difference for the allelic frequency (p_All = 0.0072). The Apa I alleles were also found to be associated with MS (p_All = 0.04) but genotype frequencies were not significantly different from controls (p_Gen = 0.1). The Taq and Apa variants are in very strong and significant linkage disequilibrium (D' = 0.96, P < 0.0001). The genotypic associations are strongest for the progressive forms of MS (SP-MS and PP-MS). Our results support a role for the VDR gene increasing

Search for direct production of charginos and neutralinos in events with three leptons and missing transverse momentum in √s = 7 TeV pp collisions with the ATLAS detector

A search for the direct production of charginos and neutralinos in final states with three electrons or muons and missing transverse momentum is presented. The analysis is based on 4.7 fb−1 of proton–proton collision data delivered by the Large Hadron Collider and recorded with the ATLAS detector. Observations are consistent with Standard Model expectations in three signal regions that are either depleted or enriched in Z-boson decays. Upper limits at 95% confidence level are set in R-parity conserving phenomenological minimal supersymmetric models and in simplified models, significantly extending previous results

Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine Programme

Introduction: Phase I of the Cancer Research UK Stratified Medicine Programme (SMP1) was designed to roll out molecular pathology testing nationwide at the point of cancer diagnosis, as well as facilitate an infrastructure where surplus cancer tissue could be used for research. It offered a non-trial setting to examine common UK cancer genetics in a real-world context. Methods: A total of 26 sites in England, Wales and Scotland, recruited samples from 7814 patients for genetic examination between 2011 and 2013. Tumour types involved were breast, colorectal, lung, prostate, ovarian cancer and malignant melanoma. Centralised molecular testing of surplus material from resections or biopsies of primary/metastatic tissue was performed, with samples examined for 3–5 genetic alterations deemed to be of key interest in site-specific cancers by the National Cancer Research Institute Clinical Study groups. Results: 10 754 patients (98% of those approached) consented to participate, from which 7814 tumour samples were genetically analysed. In total, 53% had at least one genetic aberration detected. From 1885 patients with lung cancer, KRAS mutation was noted to be highly prevalent in adenocarcinoma (37%). In breast cancer (1873 patients), there was a striking contrast in TP53 mutation incidence between patients with ductal cancer (27.3%) and lobular cancer (3.4%). Vast inter-tumour heterogeneity of colorectal cancer (1550 patients) was observed, including myriad double and triple combinations of genetic aberrations. Significant losses of important clinical information included smoking status in lung cancer and loss of distinction between low-grade and high-grade serous ovarian cancers. Conclusion: Nationwide molecular pathology testing in a non-trial setting is feasible. The experience with SMP1 has been used to inform ongoing CRUK flagship programmes such as the CRUK National Lung MATRIX trial and TRACERx